nodes	percent_of_prediction	percent_of_DWPC	metapath
Terconazole—Ketoconazole—CYP11A1—type 2 diabetes mellitus	0.00761	0.247	CrCbGaD
Terconazole—Posaconazole—CYP3A4—type 2 diabetes mellitus	0.00587	0.191	CrCbGaD
Terconazole—Itraconazole—CYP2E1—type 2 diabetes mellitus	0.0049	0.159	CrCbGaD
Terconazole—Ketoconazole—AR—type 2 diabetes mellitus	0.0047	0.153	CrCbGaD
Terconazole—Headache—Linagliptin—type 2 diabetes mellitus	0.00383	0.00395	CcSEcCtD
Terconazole—Anaphylactic shock—Glimepiride—type 2 diabetes mellitus	0.00383	0.00395	CcSEcCtD
Terconazole—Anaphylactic shock—Sitagliptin—type 2 diabetes mellitus	0.00381	0.00394	CcSEcCtD
Terconazole—Dizziness—Nateglinide—type 2 diabetes mellitus	0.00379	0.00391	CcSEcCtD
Terconazole—Vomiting—Acarbose—type 2 diabetes mellitus	0.00378	0.0039	CcSEcCtD
Terconazole—Rash—Acarbose—type 2 diabetes mellitus	0.00374	0.00386	CcSEcCtD
Terconazole—Dermatitis—Acarbose—type 2 diabetes mellitus	0.00374	0.00386	CcSEcCtD
Terconazole—Musculoskeletal discomfort—Glipizide—type 2 diabetes mellitus	0.00374	0.00385	CcSEcCtD
Terconazole—Urticaria—Rosiglitazone—type 2 diabetes mellitus	0.00372	0.00384	CcSEcCtD
Terconazole—Nausea—Chlorpropamide—type 2 diabetes mellitus	0.00367	0.00379	CcSEcCtD
Terconazole—Nausea—Tolazamide—type 2 diabetes mellitus	0.00367	0.00379	CcSEcCtD
Terconazole—Hypersensitivity—Repaglinide—type 2 diabetes mellitus	0.00365	0.00377	CcSEcCtD
Terconazole—Vomiting—Nateglinide—type 2 diabetes mellitus	0.00364	0.00376	CcSEcCtD
Terconazole—Rash—Nateglinide—type 2 diabetes mellitus	0.00361	0.00372	CcSEcCtD
Terconazole—Dermatitis—Nateglinide—type 2 diabetes mellitus	0.00361	0.00372	CcSEcCtD
Terconazole—Musculoskeletal discomfort—Pioglitazone—type 2 diabetes mellitus	0.00358	0.00369	CcSEcCtD
Terconazole—Chills—Gliclazide—type 2 diabetes mellitus	0.00358	0.00369	CcSEcCtD
Terconazole—Nausea—Acarbose—type 2 diabetes mellitus	0.00353	0.00364	CcSEcCtD
Terconazole—Pain—Glipizide—type 2 diabetes mellitus	0.00351	0.00362	CcSEcCtD
Terconazole—Pruritus—Repaglinide—type 2 diabetes mellitus	0.00351	0.00362	CcSEcCtD
Terconazole—Musculoskeletal discomfort—Sitagliptin—type 2 diabetes mellitus	0.00347	0.00359	CcSEcCtD
Terconazole—Nausea—Nateglinide—type 2 diabetes mellitus	0.0034	0.00351	CcSEcCtD
Terconazole—Feeling abnormal—Glipizide—type 2 diabetes mellitus	0.00338	0.00349	CcSEcCtD
Terconazole—Asthenia—Rosiglitazone—type 2 diabetes mellitus	0.00336	0.00347	CcSEcCtD
Terconazole—Gastrointestinal pain—Glipizide—type 2 diabetes mellitus	0.00335	0.00346	CcSEcCtD
Terconazole—Pruritus—Rosiglitazone—type 2 diabetes mellitus	0.00331	0.00342	CcSEcCtD
Terconazole—Toxic epidermal necrolysis—Ramipril—type 2 diabetes mellitus	0.00331	0.00341	CcSEcCtD
Terconazole—Myalgia—Glyburide—type 2 diabetes mellitus	0.00329	0.0034	CcSEcCtD
Terconazole—Arthralgia—Glyburide—type 2 diabetes mellitus	0.00329	0.0034	CcSEcCtD
Terconazole—Pain—Sitagliptin—type 2 diabetes mellitus	0.00326	0.00337	CcSEcCtD
Terconazole—Urticaria—Glipizide—type 2 diabetes mellitus	0.00326	0.00336	CcSEcCtD
Terconazole—Abdominal pain—Glipizide—type 2 diabetes mellitus	0.00324	0.00334	CcSEcCtD
Terconazole—Feeling abnormal—Pioglitazone—type 2 diabetes mellitus	0.00324	0.00334	CcSEcCtD
Terconazole—Ill-defined disorder—Gliclazide—type 2 diabetes mellitus	0.00322	0.00332	CcSEcCtD
Terconazole—Feeling abnormal—Glimepiride—type 2 diabetes mellitus	0.00315	0.00325	CcSEcCtD
Terconazole—Vomiting—Repaglinide—type 2 diabetes mellitus	0.00315	0.00325	CcSEcCtD
Terconazole—Feeling abnormal—Sitagliptin—type 2 diabetes mellitus	0.00314	0.00324	CcSEcCtD
Terconazole—Malaise—Gliclazide—type 2 diabetes mellitus	0.00313	0.00323	CcSEcCtD
Terconazole—Gastrointestinal pain—Glimepiride—type 2 diabetes mellitus	0.00313	0.00323	CcSEcCtD
Terconazole—Rash—Repaglinide—type 2 diabetes mellitus	0.00312	0.00322	CcSEcCtD
Terconazole—Bronchospasm—Ramipril—type 2 diabetes mellitus	0.00312	0.00322	CcSEcCtD
Terconazole—Dermatitis—Repaglinide—type 2 diabetes mellitus	0.00312	0.00322	CcSEcCtD
Terconazole—Urticaria—Pioglitazone—type 2 diabetes mellitus	0.00312	0.00322	CcSEcCtD
Terconazole—Gastrointestinal pain—Sitagliptin—type 2 diabetes mellitus	0.00312	0.00322	CcSEcCtD
Terconazole—Headache—Repaglinide—type 2 diabetes mellitus	0.0031	0.0032	CcSEcCtD
Terconazole—Dizziness—Rosiglitazone—type 2 diabetes mellitus	0.0031	0.0032	CcSEcCtD
Terconazole—Itraconazole—CYP3A4—type 2 diabetes mellitus	0.00309	0.1	CrCbGaD
Terconazole—Urticaria—Glimepiride—type 2 diabetes mellitus	0.00304	0.00314	CcSEcCtD
Terconazole—Urticaria—Sitagliptin—type 2 diabetes mellitus	0.00303	0.00313	CcSEcCtD
Terconazole—Abdominal pain—Glimepiride—type 2 diabetes mellitus	0.00302	0.00312	CcSEcCtD
Terconazole—Hypersensitivity—Glipizide—type 2 diabetes mellitus	0.00302	0.00312	CcSEcCtD
Terconazole—Abdominal pain—Sitagliptin—type 2 diabetes mellitus	0.00302	0.00311	CcSEcCtD
Terconazole—Chills—Metformin—type 2 diabetes mellitus	0.00299	0.00309	CcSEcCtD
Terconazole—Arthralgia—Gliclazide—type 2 diabetes mellitus	0.00296	0.00305	CcSEcCtD
Terconazole—Myalgia—Gliclazide—type 2 diabetes mellitus	0.00296	0.00305	CcSEcCtD
Terconazole—Rash—Rosiglitazone—type 2 diabetes mellitus	0.00295	0.00305	CcSEcCtD
Terconazole—Dermatitis—Rosiglitazone—type 2 diabetes mellitus	0.00295	0.00304	CcSEcCtD
Terconazole—Nausea—Repaglinide—type 2 diabetes mellitus	0.00294	0.00304	CcSEcCtD
Terconazole—Asthenia—Glipizide—type 2 diabetes mellitus	0.00294	0.00304	CcSEcCtD
Terconazole—Headache—Rosiglitazone—type 2 diabetes mellitus	0.00293	0.00303	CcSEcCtD
Terconazole—Ill-defined disorder—Orlistat—type 2 diabetes mellitus	0.00292	0.00302	CcSEcCtD
Terconazole—Discomfort—Gliclazide—type 2 diabetes mellitus	0.00292	0.00301	CcSEcCtD
Terconazole—Pruritus—Glipizide—type 2 diabetes mellitus	0.0029	0.00299	CcSEcCtD
Terconazole—Hypersensitivity—Pioglitazone—type 2 diabetes mellitus	0.00289	0.00299	CcSEcCtD
Terconazole—Musculoskeletal discomfort—Glyburide—type 2 diabetes mellitus	0.00287	0.00297	CcSEcCtD
Terconazole—Feeling abnormal—Bromocriptine—type 2 diabetes mellitus	0.00284	0.00293	CcSEcCtD
Terconazole—Malaise—Orlistat—type 2 diabetes mellitus	0.00284	0.00293	CcSEcCtD
Terconazole—Chills—Irbesartan—type 2 diabetes mellitus	0.00283	0.00292	CcSEcCtD
Terconazole—Gastrointestinal pain—Bromocriptine—type 2 diabetes mellitus	0.00282	0.00291	CcSEcCtD
Terconazole—Hypersensitivity—Glimepiride—type 2 diabetes mellitus	0.00282	0.00291	CcSEcCtD
Terconazole—Asthenia—Pioglitazone—type 2 diabetes mellitus	0.00282	0.00291	CcSEcCtD
Terconazole—Hypersensitivity—Sitagliptin—type 2 diabetes mellitus	0.00281	0.0029	CcSEcCtD
Terconazole—Ketoconazole—CYP1A2—type 2 diabetes mellitus	0.00279	0.0906	CrCbGaD
Terconazole—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.00278	0.00287	CcSEcCtD
Terconazole—Asthenia—Glimepiride—type 2 diabetes mellitus	0.00275	0.00283	CcSEcCtD
Terconazole—Urticaria—Bromocriptine—type 2 diabetes mellitus	0.00274	0.00283	CcSEcCtD
Terconazole—Asthenia—Sitagliptin—type 2 diabetes mellitus	0.00274	0.00282	CcSEcCtD
Terconazole—Abdominal pain—Bromocriptine—type 2 diabetes mellitus	0.00273	0.00282	CcSEcCtD
Terconazole—Body temperature increased—Bromocriptine—type 2 diabetes mellitus	0.00273	0.00282	CcSEcCtD
Terconazole—Arthralgia—Valsartan—type 2 diabetes mellitus	0.00272	0.0028	CcSEcCtD
Terconazole—Myalgia—Valsartan—type 2 diabetes mellitus	0.00272	0.0028	CcSEcCtD
Terconazole—Dizziness—Glipizide—type 2 diabetes mellitus	0.00271	0.0028	CcSEcCtD
Terconazole—Pruritus—Glimepiride—type 2 diabetes mellitus	0.00271	0.00279	CcSEcCtD
Terconazole—Ill-defined disorder—Metformin—type 2 diabetes mellitus	0.0027	0.00278	CcSEcCtD
Terconazole—Myalgia—Orlistat—type 2 diabetes mellitus	0.00268	0.00277	CcSEcCtD
Terconazole—Discomfort—Orlistat—type 2 diabetes mellitus	0.00265	0.00274	CcSEcCtD
Terconazole—Malaise—Metformin—type 2 diabetes mellitus	0.00262	0.0027	CcSEcCtD
Terconazole—Vomiting—Glipizide—type 2 diabetes mellitus	0.00261	0.00269	CcSEcCtD
Terconazole—Anaphylactic shock—Valsartan—type 2 diabetes mellitus	0.0026	0.00269	CcSEcCtD
Terconazole—Feeling abnormal—Glyburide—type 2 diabetes mellitus	0.0026	0.00268	CcSEcCtD
Terconazole—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.0026	0.00268	CcSEcCtD
Terconazole—Rash—Glipizide—type 2 diabetes mellitus	0.00259	0.00267	CcSEcCtD
Terconazole—Dermatitis—Glipizide—type 2 diabetes mellitus	0.00258	0.00266	CcSEcCtD
Terconazole—Musculoskeletal discomfort—Gliclazide—type 2 diabetes mellitus	0.00258	0.00266	CcSEcCtD
Terconazole—Gastrointestinal pain—Glyburide—type 2 diabetes mellitus	0.00258	0.00266	CcSEcCtD
Terconazole—Anaphylactic shock—Orlistat—type 2 diabetes mellitus	0.00257	0.00265	CcSEcCtD
Terconazole—Headache—Glipizide—type 2 diabetes mellitus	0.00257	0.00265	CcSEcCtD
Terconazole—Ill-defined disorder—Irbesartan—type 2 diabetes mellitus	0.00254	0.00262	CcSEcCtD
Terconazole—Dizziness—Glimepiride—type 2 diabetes mellitus	0.00253	0.00261	CcSEcCtD
Terconazole—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.00252	0.0026	CcSEcCtD
Terconazole—Urticaria—Glyburide—type 2 diabetes mellitus	0.00251	0.00259	CcSEcCtD
Terconazole—Abdominal pain—Glyburide—type 2 diabetes mellitus	0.00249	0.00257	CcSEcCtD
Terconazole—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.00248	0.00256	CcSEcCtD
Terconazole—Myalgia—Metformin—type 2 diabetes mellitus	0.00247	0.00255	CcSEcCtD
Terconazole—Malaise—Irbesartan—type 2 diabetes mellitus	0.00247	0.00255	CcSEcCtD
Terconazole—Headache—Pioglitazone—type 2 diabetes mellitus	0.00246	0.00254	CcSEcCtD
Terconazole—Discomfort—Metformin—type 2 diabetes mellitus	0.00244	0.00252	CcSEcCtD
Terconazole—Nausea—Glipizide—type 2 diabetes mellitus	0.00244	0.00251	CcSEcCtD
Terconazole—Vomiting—Glimepiride—type 2 diabetes mellitus	0.00243	0.00251	CcSEcCtD
Terconazole—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.00243	0.0025	CcSEcCtD
Terconazole—Pain—Gliclazide—type 2 diabetes mellitus	0.00242	0.0025	CcSEcCtD
Terconazole—Rash—Glimepiride—type 2 diabetes mellitus	0.00241	0.00249	CcSEcCtD
Terconazole—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.00241	0.00249	CcSEcCtD
Terconazole—Rash—Sitagliptin—type 2 diabetes mellitus	0.0024	0.00248	CcSEcCtD
Terconazole—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.0024	0.00248	CcSEcCtD
Terconazole—Headache—Glimepiride—type 2 diabetes mellitus	0.0024	0.00247	CcSEcCtD
Terconazole—Ill-defined disorder—Losartan—type 2 diabetes mellitus	0.00239	0.00247	CcSEcCtD
Terconazole—Headache—Sitagliptin—type 2 diabetes mellitus	0.00239	0.00247	CcSEcCtD
Terconazole—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	0.00237	0.00245	CcSEcCtD
Terconazole—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	0.00234	0.00242	CcSEcCtD
Terconazole—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	0.00233	0.00241	CcSEcCtD
Terconazole—Arthralgia—Irbesartan—type 2 diabetes mellitus	0.00233	0.00241	CcSEcCtD
Terconazole—Myalgia—Irbesartan—type 2 diabetes mellitus	0.00233	0.00241	CcSEcCtD
Terconazole—Malaise—Losartan—type 2 diabetes mellitus	0.00233	0.0024	CcSEcCtD
Terconazole—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.00232	0.0024	CcSEcCtD
Terconazole—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	0.00232	0.00239	CcSEcCtD
Terconazole—Discomfort—Irbesartan—type 2 diabetes mellitus	0.00231	0.00238	CcSEcCtD
Terconazole—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.00228	0.00236	CcSEcCtD
Terconazole—Nausea—Glimepiride—type 2 diabetes mellitus	0.00227	0.00234	CcSEcCtD
Terconazole—Nausea—Sitagliptin—type 2 diabetes mellitus	0.00227	0.00234	CcSEcCtD
Terconazole—Asthenia—Glyburide—type 2 diabetes mellitus	0.00226	0.00234	CcSEcCtD
Terconazole—Urticaria—Gliclazide—type 2 diabetes mellitus	0.00225	0.00232	CcSEcCtD
Terconazole—Body temperature increased—Gliclazide—type 2 diabetes mellitus	0.00224	0.00231	CcSEcCtD
Terconazole—Abdominal pain—Gliclazide—type 2 diabetes mellitus	0.00224	0.00231	CcSEcCtD
Terconazole—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	0.00224	0.00231	CcSEcCtD
Terconazole—Pruritus—Glyburide—type 2 diabetes mellitus	0.00223	0.0023	CcSEcCtD
Terconazole—Pain—Orlistat—type 2 diabetes mellitus	0.0022	0.00227	CcSEcCtD
Terconazole—Arthralgia—Losartan—type 2 diabetes mellitus	0.0022	0.00227	CcSEcCtD
Terconazole—Myalgia—Losartan—type 2 diabetes mellitus	0.0022	0.00227	CcSEcCtD
Terconazole—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.00219	0.00226	CcSEcCtD
Terconazole—Rash—Bromocriptine—type 2 diabetes mellitus	0.00218	0.00225	CcSEcCtD
Terconazole—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.00217	0.00224	CcSEcCtD
Terconazole—Discomfort—Losartan—type 2 diabetes mellitus	0.00217	0.00224	CcSEcCtD
Terconazole—Headache—Bromocriptine—type 2 diabetes mellitus	0.00216	0.00223	CcSEcCtD
Terconazole—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	0.00216	0.00223	CcSEcCtD
Terconazole—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	0.00213	0.0022	CcSEcCtD
Terconazole—Feeling abnormal—Orlistat—type 2 diabetes mellitus	0.00212	0.00219	CcSEcCtD
Terconazole—Anaphylactic shock—Losartan—type 2 diabetes mellitus	0.00211	0.00217	CcSEcCtD
Terconazole—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	0.0021	0.00217	CcSEcCtD
Terconazole—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.00209	0.00215	CcSEcCtD
Terconazole—Urticaria—Valsartan—type 2 diabetes mellitus	0.00207	0.00213	CcSEcCtD
Terconazole—Abdominal pain—Valsartan—type 2 diabetes mellitus	0.00206	0.00212	CcSEcCtD
Terconazole—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	0.00205	0.00212	CcSEcCtD
Terconazole—Nausea—Bromocriptine—type 2 diabetes mellitus	0.00205	0.00212	CcSEcCtD
Terconazole—Urticaria—Orlistat—type 2 diabetes mellitus	0.00204	0.00211	CcSEcCtD
Terconazole—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	0.00204	0.0021	CcSEcCtD
Terconazole—Abdominal pain—Orlistat—type 2 diabetes mellitus	0.00203	0.0021	CcSEcCtD
Terconazole—Body temperature increased—Orlistat—type 2 diabetes mellitus	0.00203	0.0021	CcSEcCtD
Terconazole—Asthenia—Gliclazide—type 2 diabetes mellitus	0.00203	0.0021	CcSEcCtD
Terconazole—Vomiting—Glyburide—type 2 diabetes mellitus	0.00201	0.00207	CcSEcCtD
Terconazole—Pruritus—Gliclazide—type 2 diabetes mellitus	0.002	0.00207	CcSEcCtD
Terconazole—Malaise—Ramipril—type 2 diabetes mellitus	0.00199	0.00206	CcSEcCtD
Terconazole—Rash—Glyburide—type 2 diabetes mellitus	0.00199	0.00205	CcSEcCtD
Terconazole—Dermatitis—Glyburide—type 2 diabetes mellitus	0.00199	0.00205	CcSEcCtD
Terconazole—Headache—Glyburide—type 2 diabetes mellitus	0.00198	0.00204	CcSEcCtD
Terconazole—Feeling abnormal—Metformin—type 2 diabetes mellitus	0.00195	0.00202	CcSEcCtD
Terconazole—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	0.00194	0.002	CcSEcCtD
Terconazole—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	0.00192	0.00198	CcSEcCtD
Terconazole—Hypersensitivity—Valsartan—type 2 diabetes mellitus	0.00192	0.00198	CcSEcCtD
Terconazole—Pain—Irbesartan—type 2 diabetes mellitus	0.00191	0.00197	CcSEcCtD
Terconazole—Hypersensitivity—Orlistat—type 2 diabetes mellitus	0.0019	0.00196	CcSEcCtD
Terconazole—Urticaria—Metformin—type 2 diabetes mellitus	0.00188	0.00194	CcSEcCtD
Terconazole—Myalgia—Ramipril—type 2 diabetes mellitus	0.00188	0.00194	CcSEcCtD
Terconazole—Arthralgia—Ramipril—type 2 diabetes mellitus	0.00188	0.00194	CcSEcCtD
Terconazole—Nausea—Glyburide—type 2 diabetes mellitus	0.00187	0.00193	CcSEcCtD
Terconazole—Abdominal pain—Metformin—type 2 diabetes mellitus	0.00187	0.00193	CcSEcCtD
Terconazole—Dizziness—Gliclazide—type 2 diabetes mellitus	0.00187	0.00193	CcSEcCtD
Terconazole—Asthenia—Valsartan—type 2 diabetes mellitus	0.00187	0.00193	CcSEcCtD
Terconazole—Discomfort—Ramipril—type 2 diabetes mellitus	0.00186	0.00192	CcSEcCtD
Terconazole—Ketoconazole—CYP3A4—type 2 diabetes mellitus	0.00185	0.06	CrCbGaD
Terconazole—Asthenia—Orlistat—type 2 diabetes mellitus	0.00185	0.0019	CcSEcCtD
Terconazole—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	0.00184	0.0019	CcSEcCtD
Terconazole—Pruritus—Valsartan—type 2 diabetes mellitus	0.00184	0.0019	CcSEcCtD
Terconazole—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	0.00183	0.00189	CcSEcCtD
Terconazole—Pruritus—Orlistat—type 2 diabetes mellitus	0.00182	0.00188	CcSEcCtD
Terconazole—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	0.00181	0.00186	CcSEcCtD
Terconazole—Vomiting—Gliclazide—type 2 diabetes mellitus	0.0018	0.00186	CcSEcCtD
Terconazole—Pain—Losartan—type 2 diabetes mellitus	0.0018	0.00186	CcSEcCtD
Terconazole—Rash—Gliclazide—type 2 diabetes mellitus	0.00179	0.00184	CcSEcCtD
Terconazole—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.00178	0.00184	CcSEcCtD
Terconazole—Urticaria—Irbesartan—type 2 diabetes mellitus	0.00178	0.00183	CcSEcCtD
Terconazole—Headache—Gliclazide—type 2 diabetes mellitus	0.00178	0.00183	CcSEcCtD
Terconazole—Abdominal pain—Irbesartan—type 2 diabetes mellitus	0.00177	0.00182	CcSEcCtD
Terconazole—Body temperature increased—Irbesartan—type 2 diabetes mellitus	0.00177	0.00182	CcSEcCtD
Terconazole—Feeling abnormal—Losartan—type 2 diabetes mellitus	0.00173	0.00179	CcSEcCtD
Terconazole—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	0.00172	0.00178	CcSEcCtD
Terconazole—Dizziness—Valsartan—type 2 diabetes mellitus	0.00172	0.00178	CcSEcCtD
Terconazole—Dizziness—Orlistat—type 2 diabetes mellitus	0.0017	0.00176	CcSEcCtD
Terconazole—Asthenia—Metformin—type 2 diabetes mellitus	0.0017	0.00175	CcSEcCtD
Terconazole—Nausea—Gliclazide—type 2 diabetes mellitus	0.00168	0.00174	CcSEcCtD
Terconazole—Pruritus—Metformin—type 2 diabetes mellitus	0.00168	0.00173	CcSEcCtD
Terconazole—Urticaria—Losartan—type 2 diabetes mellitus	0.00167	0.00173	CcSEcCtD
Terconazole—Abdominal pain—Losartan—type 2 diabetes mellitus	0.00166	0.00172	CcSEcCtD
Terconazole—Body temperature increased—Losartan—type 2 diabetes mellitus	0.00166	0.00172	CcSEcCtD
Terconazole—Vomiting—Valsartan—type 2 diabetes mellitus	0.00166	0.00171	CcSEcCtD
Terconazole—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	0.00165	0.0017	CcSEcCtD
Terconazole—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	0.00164	0.0017	CcSEcCtD
Terconazole—Rash—Valsartan—type 2 diabetes mellitus	0.00164	0.00169	CcSEcCtD
Terconazole—Dermatitis—Valsartan—type 2 diabetes mellitus	0.00164	0.00169	CcSEcCtD
Terconazole—Vomiting—Orlistat—type 2 diabetes mellitus	0.00164	0.00169	CcSEcCtD
Terconazole—Headache—Valsartan—type 2 diabetes mellitus	0.00163	0.00168	CcSEcCtD
Terconazole—Rash—Orlistat—type 2 diabetes mellitus	0.00162	0.00167	CcSEcCtD
Terconazole—Dermatitis—Orlistat—type 2 diabetes mellitus	0.00162	0.00167	CcSEcCtD
Terconazole—Headache—Orlistat—type 2 diabetes mellitus	0.00161	0.00166	CcSEcCtD
Terconazole—Asthenia—Irbesartan—type 2 diabetes mellitus	0.00161	0.00166	CcSEcCtD
Terconazole—Pruritus—Irbesartan—type 2 diabetes mellitus	0.00158	0.00163	CcSEcCtD
Terconazole—Dizziness—Metformin—type 2 diabetes mellitus	0.00157	0.00162	CcSEcCtD
Terconazole—Hypersensitivity—Losartan—type 2 diabetes mellitus	0.00155	0.0016	CcSEcCtD
Terconazole—Nausea—Valsartan—type 2 diabetes mellitus	0.00155	0.0016	CcSEcCtD
Terconazole—Nausea—Orlistat—type 2 diabetes mellitus	0.00153	0.00158	CcSEcCtD
Terconazole—Asthenia—Losartan—type 2 diabetes mellitus	0.00151	0.00156	CcSEcCtD
Terconazole—Vomiting—Metformin—type 2 diabetes mellitus	0.00151	0.00156	CcSEcCtD
Terconazole—Rash—Metformin—type 2 diabetes mellitus	0.00149	0.00154	CcSEcCtD
Terconazole—Dermatitis—Metformin—type 2 diabetes mellitus	0.00149	0.00154	CcSEcCtD
Terconazole—Pruritus—Losartan—type 2 diabetes mellitus	0.00149	0.00154	CcSEcCtD
Terconazole—Feeling abnormal—Ramipril—type 2 diabetes mellitus	0.00149	0.00153	CcSEcCtD
Terconazole—Headache—Metformin—type 2 diabetes mellitus	0.00149	0.00153	CcSEcCtD
Terconazole—Dizziness—Irbesartan—type 2 diabetes mellitus	0.00148	0.00153	CcSEcCtD
Terconazole—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	0.00148	0.00152	CcSEcCtD
Terconazole—Urticaria—Ramipril—type 2 diabetes mellitus	0.00143	0.00148	CcSEcCtD
Terconazole—Abdominal pain—Ramipril—type 2 diabetes mellitus	0.00143	0.00147	CcSEcCtD
Terconazole—Body temperature increased—Ramipril—type 2 diabetes mellitus	0.00143	0.00147	CcSEcCtD
Terconazole—Vomiting—Irbesartan—type 2 diabetes mellitus	0.00142	0.00147	CcSEcCtD
Terconazole—Rash—Irbesartan—type 2 diabetes mellitus	0.00141	0.00146	CcSEcCtD
Terconazole—Dermatitis—Irbesartan—type 2 diabetes mellitus	0.00141	0.00145	CcSEcCtD
Terconazole—Nausea—Metformin—type 2 diabetes mellitus	0.00141	0.00145	CcSEcCtD
Terconazole—Headache—Irbesartan—type 2 diabetes mellitus	0.0014	0.00145	CcSEcCtD
Terconazole—Dizziness—Losartan—type 2 diabetes mellitus	0.00139	0.00144	CcSEcCtD
Terconazole—Vomiting—Losartan—type 2 diabetes mellitus	0.00134	0.00138	CcSEcCtD
Terconazole—Hypersensitivity—Ramipril—type 2 diabetes mellitus	0.00133	0.00137	CcSEcCtD
Terconazole—Nausea—Irbesartan—type 2 diabetes mellitus	0.00133	0.00137	CcSEcCtD
Terconazole—Rash—Losartan—type 2 diabetes mellitus	0.00133	0.00137	CcSEcCtD
Terconazole—Dermatitis—Losartan—type 2 diabetes mellitus	0.00133	0.00137	CcSEcCtD
Terconazole—Headache—Losartan—type 2 diabetes mellitus	0.00132	0.00136	CcSEcCtD
Terconazole—Asthenia—Ramipril—type 2 diabetes mellitus	0.0013	0.00134	CcSEcCtD
Terconazole—Pruritus—Ramipril—type 2 diabetes mellitus	0.00128	0.00132	CcSEcCtD
Terconazole—Nausea—Losartan—type 2 diabetes mellitus	0.00125	0.00129	CcSEcCtD
Terconazole—Dizziness—Ramipril—type 2 diabetes mellitus	0.00119	0.00123	CcSEcCtD
Terconazole—Vomiting—Ramipril—type 2 diabetes mellitus	0.00115	0.00118	CcSEcCtD
Terconazole—Rash—Ramipril—type 2 diabetes mellitus	0.00114	0.00117	CcSEcCtD
Terconazole—Dermatitis—Ramipril—type 2 diabetes mellitus	0.00114	0.00117	CcSEcCtD
Terconazole—Headache—Ramipril—type 2 diabetes mellitus	0.00113	0.00117	CcSEcCtD
Terconazole—Nausea—Ramipril—type 2 diabetes mellitus	0.00107	0.00111	CcSEcCtD
